NCT05633420View on ClinicalTrials.gov

Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 24, 2022

Primary Completion Date

September 6, 2022

Study Completion Date

November 20, 2022

Conditions
COVID-19
Interventions
DRUG

Pyramax

"Participant body weight~* ≥65 kg (Pyramax 4 tablets)~* ≥45 kg and \<65 kg (Pyramax 3 tablets)"

Trial Locations (2)

10380

Inje University Ilsan Paik Hospital, Goyang-si

22332

Inha University Hospital, Incheon

All Listed Sponsors
lead

Shin Poong Pharmaceutical Co. Ltd.

INDUSTRY